Lentiviral shRNA against KCa3.1 inhibits allergic response in allergic rhinitis and suppresses mast cell activity via PI3K/AKT signaling pathway.
about
Lentiviral shRNA against KCa3.1 inhibits allergic response in allergic rhinitis and suppresses mast cell activity via PI3K/AKT signaling pathway.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Lentiviral shRNA against KCa3. ...... ia PI3K/AKT signaling pathway.
@ast
Lentiviral shRNA against KCa3. ...... ia PI3K/AKT signaling pathway.
@en
type
label
Lentiviral shRNA against KCa3. ...... ia PI3K/AKT signaling pathway.
@ast
Lentiviral shRNA against KCa3. ...... ia PI3K/AKT signaling pathway.
@en
prefLabel
Lentiviral shRNA against KCa3. ...... ia PI3K/AKT signaling pathway.
@ast
Lentiviral shRNA against KCa3. ...... ia PI3K/AKT signaling pathway.
@en
P2093
P2860
P356
P1433
P1476
Lentiviral shRNA against KCa3. ...... ia PI3K/AKT signaling pathway.
@en
P2093
P2860
P2888
P356
10.1038/SREP13127
P407
P577
2015-08-14T00:00:00Z